These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years. Chaturvedi S; DeBaun MR Am J Hematol; 2016 Jan; 91(1):5-14. PubMed ID: 26547630 [TBL] [Abstract][Full Text] [Related]
7. Treatment Options for Sickle Cell Disease. Meier ER Pediatr Clin North Am; 2018 Jun; 65(3):427-443. PubMed ID: 29803275 [TBL] [Abstract][Full Text] [Related]
8. The case for and against initiating either hydroxyurea therapy, blood transfusion therapy or hematopoietic stem cell transplant in asymptomatic children with sickle cell disease. Kassim AA; DeBaun MR Expert Opin Pharmacother; 2014 Feb; 15(3):325-36. PubMed ID: 24392871 [TBL] [Abstract][Full Text] [Related]
9. Advances in the Treatment of Sickle Cell Disease. Kapoor S; Little JA; Pecker LH Mayo Clin Proc; 2018 Dec; 93(12):1810-1824. PubMed ID: 30414734 [TBL] [Abstract][Full Text] [Related]
10. Approach to the vaso-occlusive crisis in adults with sickle cell disease. Yale SH; Nagib N; Guthrie T Am Fam Physician; 2000 Mar; 61(5):1349-56, 1363-4. PubMed ID: 10735342 [TBL] [Abstract][Full Text] [Related]
11. Sickle cell disease: current treatment and emerging therapies. Neumayr LD; Hoppe CC; Brown C Am J Manag Care; 2019 Nov; 25(18 Suppl):S335-S343. PubMed ID: 31809007 [TBL] [Abstract][Full Text] [Related]
14. Regular long-term red blood cell transfusions for managing chronic chest complications in sickle cell disease. Estcourt LJ; Fortin PM; Hopewell S; Trivella M; Hambleton IR; Cho G Cochrane Database Syst Rev; 2016 May; (5):CD008360. PubMed ID: 27198469 [TBL] [Abstract][Full Text] [Related]
15. Sickle cell disease--pathophysiology and treatment. Redding-Lallinger R; Knoll C Curr Probl Pediatr Adolesc Health Care; 2006; 36(10):346-76. PubMed ID: 17055417 [No Abstract] [Full Text] [Related]
16. Sickle cell disease: What all PAs should know. Kayinqo G JAAPA; 2012 Sep; 25(9):19-20. PubMed ID: 22991882 [No Abstract] [Full Text] [Related]
17. Sickle Cell Disease: Monitoring, Current Treatment, and Therapeutics Under Development. Hoppe C; Neumayr L Hematol Oncol Clin North Am; 2019 Jun; 33(3):355-371. PubMed ID: 31030807 [TBL] [Abstract][Full Text] [Related]
18. [Is therapeutic progress in the management of sickle cell disease applicable in sub-Saharan Africa?]. De Montalembert M; Tshilolo L Med Trop (Mars); 2007 Dec; 67(6):612-6. PubMed ID: 18300525 [TBL] [Abstract][Full Text] [Related]
19. Sickle cell disease in North Europe. Howard J; Davies SC Scand J Clin Lab Invest; 2007; 67(1):27-38. PubMed ID: 17365983 [TBL] [Abstract][Full Text] [Related]
20. Clinical Features of β-Thalassemia and Sickle Cell Disease. McGann PT; Nero AC; Ware RE Adv Exp Med Biol; 2017; 1013():1-26. PubMed ID: 29127675 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]